Company Search:
Advanced Search
Sponsored Links
Burzynski Research Institute, Inc. Company Snapshot
Burzynski Research Institute, Inc. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Burzynski Research Institute with three other pharmaceutical manufacturers in North America: Brainstorm Cell Therapeutics Inc. (2002 sales of $22,900.00 of which 100% was Licensed Products), UMeWorld Ltd ($282.00 of which 100% was Therapeutic Products), and Lescarden, Inc. ($66,929.00 of which 100% was Ethical Drug Manufacturers).

Sales Analysis.
  Stock Performance Chart for Burzynski Research Institute, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/18/2018): .05
(Figures in U.S. Dollars)
1 Week 8.9%   13 Weeks -18.3%  
4 Weeks n/a   52 Weeks -34.7%  
Burzynski Research Institute, Inc. Key Data:
  Ticker: BZYR Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2002 Sales 3,000
(Year Ending Jan 2003).
Employees: 2
  Currency: U.S. Dollars Market Cap: 6,440,974
  Fiscal Yr Ends: February Shares Outstanding: 131,448,444
  Share Type: Common Closely Held Shares: 106,480,102
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.